Botanix Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2019
Operating Revenue	2.07	2.07	3.77	2.75	6.88	7.56	Upgrade
Other Revenue	-	-	-	-	0.01	0.01	Upgrade
Revenue	2.07	2.07	3.77	2.75	6.89	7.57	Upgrade
Revenue Growth (YoY)	373.26%	-45.14%	36.94%	-60.00%	-9.07%	61.63%	Upgrade
Cost of Revenue	3.88	3.65	5.73	10.29	6.57	13.7	Upgrade
Gross Profit	-1.81	-1.58	-1.96	-7.54	0.32	-6.13	Upgrade
Selling, General & Admin	22.92	6.91	4.41	4.28	2.62	7.35	Upgrade
Other Operating Expenses	1.03	1.03	1.13	0.89	0.41	0.78	Upgrade
Operating Expenses	38.62	12.41	7.17	5.65	3.7	10.56	Upgrade
Operating Income	-40.44	-13.99	-9.13	-13.19	-3.38	-16.69	Upgrade
Interest Expense	-0.04	-0.01	-0.08	-0.04	-0.06	-0.05	Upgrade
Interest & Investment Income	1.22	0.08	0.07	0.04	0.1	0.17	Upgrade
Currency Exchange Gain (Loss)	-0.03	0.06	-0.01	0.02	-0	-0.17	Upgrade
Other Non Operating Income (Expenses)	0	-	-	-	-	-	Upgrade
Pretax Income	-39.29	-13.87	-9.15	-13.17	-3.33	-16.73	Upgrade
Net Income	-39.29	-13.87	-9.15	-13.17	-3.33	-16.73	Upgrade
Net Income to Common	-39.29	-13.87	-9.15	-13.17	-3.33	-16.73	Upgrade
Shares Outstanding (Basic)	1,691	1,502	1,154	973	973	936	Upgrade
Shares Outstanding (Diluted)	1,691	1,502	1,154	973	973	936	Upgrade
Shares Change (YoY)	24.08%	30.12%	18.58%	0.02%	3.91%	23.13%	Upgrade
EPS (Basic)	-0.02	-0.01	-0.01	-0.01	-0.00	-0.02	Upgrade
EPS (Diluted)	-0.02	-0.01	-0.01	-0.01	-0.00	-0.02	Upgrade
Free Cash Flow	-35.1	-8.24	-12.08	-11.19	-2.98	-17.45	Upgrade
Free Cash Flow Per Share	-0.02	-0.01	-0.01	-0.01	-0.00	-0.02	Upgrade
Gross Margin	-87.64%	-76.48%	-51.83%	-273.62%	4.58%	-80.87%	Upgrade
Operating Margin	-1954.28%	-676.11%	-241.93%	-478.66%	-49.08%	-220.30%	Upgrade
Profit Margin	-1898.88%	-670.20%	-242.66%	-478.10%	-48.41%	-220.90%	Upgrade
Free Cash Flow Margin	-1696.13%	-398.17%	-320.27%	-406.24%	-43.21%	-230.38%	Upgrade
EBITDA	-39.25	-13.92	-9.11	-13.17	-3.36	-16.67	Upgrade
EBITDA Margin	-	-	-241.38%	-	-48.84%	-220.14%	Upgrade
D&A For EBITDA	1.18	0.07	0.02	0.02	0.02	0.01	Upgrade
EBIT	-40.44	-13.99	-9.13	-13.19	-3.38	-16.69	Upgrade
EBIT Margin	-	-	-241.93%	-	-49.08%	-220.30%	Upgrade
Revenue as Reported	-	-	-	2.79	-	-	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.